Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
暂无分享,去创建一个
Feng Qian | Qing Zhu | M. Hussain | Munir Hussain | Jun Huang | F. Qian | Robert J. Garmise | Raja Haddadin | John Gawel | Robert Garmise | Qing Zhu | Raja Haddadin | Jun Huang | John Gawel
[1] Bruno C. Hancock,et al. Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.
[2] Feng Qian,et al. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.
[3] Simon Bates,et al. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction. , 2008, Journal of pharmaceutical sciences.
[4] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[5] C. Angell,et al. The Glass Transition of Water, Based on Hyperquenching Experiments , 2001, Science.
[6] Y. Khimyak,et al. Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. , 2009, Journal of pharmaceutical sciences.
[7] G. Van den Mooter,et al. Review: physical chemistry of solid dispersions , 2009 .
[8] David S. Jones,et al. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. , 2010, Journal of pharmaceutical sciences.
[9] L. S. Taylor,et al. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. , 2009, Molecular pharmaceutics.
[10] Lynne S Taylor,et al. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. , 2010, Molecular pharmaceutics.
[11] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] Ping Gao,et al. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. , 2008, Molecular pharmaceutics.
[13] T. Fox. Influence of Diluent and of Copolymer Composition on the Glass Temperature of a Poly-mer System , 1956 .
[14] R. T. Berendt,et al. Solid-state NMR spectroscopy in pharmaceutical research and analysis , 2006 .
[15] Bruno C. Hancock,et al. Disordered drug delivery: destiny, dynamics and the Deborah number , 2002, The Journal of pharmacy and pharmacology.
[16] Sumie Yoshioka,et al. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation. , 2007, Chemical & pharmaceutical bulletin.
[17] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.